Electrophysiological Mechanisms of the Anti-arrhythmic Effects of Omega-3 Fatty Acids

  • Eric S. Richardson
  • Paul A. Iaizzo
  • Yong-Fu Xiao
Article

Abstract

Heart rhythm disorders, or arrhythmias, are a leading cause of morbidity and mortality worldwide. Omega-3 polyunsaturated fatty acids (ω3PUFAs), commonly found in fish oils and plant seeds, have recently emerged as potential anti-arrhythmic agents. The purpose of this review is to summarize the electrophysiological basis of the anti-arrhythmic properties of ω3PUFAs from clinical, animal, and cellular research. Evidence of the anti-arrhythmic effects of ω3PUFAs originated from epidemiological studies that correlated a low incidence of sudden cardiac death with high dietary ω3PUFA intake. Subsequently, multiple clinical trials have confirmed the therapeutic effects of ω3PUFAs in preventing sudden cardiac death and multiple other arrhythmia-related disorders. This has led basic scientists to investigate the effects of ω3PUFAs on several ion channels including sodium, potassium, and calcium channels, as well as Na/Ca exchangers. Therefore, ω3PUFAs may hold promise as safe and effective anti-arrhythmic agents. Nevertheless, further research is needed in areas such as: (1) identifying which form(s) of ω3PUFAs (i.e., phospholipid, triglyceride, or free) is (are) responsible for anti-arrhythmic actions; and (2) developing reproducible methods for delivery so that the appropriate form and concentration may be present at the target site to prevent and treat arrhythmias.

Keywords

Omega-3 polyunsaturated fatty acids Anti-arrhythmic agent Heart rhythm disorder Sudden cardiac death 

References

  1. 1.
    Bang, H. O., Dyerberg, J., & Sinclair, H. M. (1980). The composition of the Eskimo food in Northwestern Greenland. The American Journal of Clinical Nutrition, 33, 2657–2661.PubMedGoogle Scholar
  2. 2.
    “Sudden cardiac death:” Available at: http://www.americanheart.org/presenter.jhtml?identifier=4741 Accessed 6 March 2009.
  3. 3.
    Lip, G. Y., & Godtfredsen, J. (2003). Cardiac arrhythmias. New York: Elsevier.Google Scholar
  4. 4.
    Leaf, A., Xiao, Y. F., Kang, J. X., & Billman, G. E. (2003). Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacology & Therapeutics, 98, 355–377.CrossRefGoogle Scholar
  5. 5.
    Mozaffarian, D., Ascherio, A., Hu, F. B., et al. (2005). Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation, 111, 157–164.CrossRefPubMedGoogle Scholar
  6. 6.
    Pawlowsky, R. J., Hibbeln, J. R., Novotny, J. A., & Salem, N., Jr. (2001). Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. Journal of Lipid Research, 42, 1257–1265.Google Scholar
  7. 7.
    Harris, W. S., Mozaffarian, D., Rimm, E., et al. (2009). Omega-6 fatty acids and risk for cardiovascular disease. Circulation, 119, 902–907.CrossRefPubMedGoogle Scholar
  8. 8.
    Demaison, L., & Moreau, D. (2002). Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: A possible mechanism of action. Cellular and Molecular Life Sciences, 59, 463–477.CrossRefPubMedGoogle Scholar
  9. 9.
    Kris-Etherton, P. M., Harris, W. S., Appel, L. J., & American Heart Association Nutrition Committee. (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106, 2747–2757.CrossRefPubMedGoogle Scholar
  10. 10.
    Daviglus, M. L., Stamler, J., Orencia, A. J., et al. (1997). Fish consumption and the 30-year risk of fatal myocardial infarction. The New England Journal of Medicine, 336, 1046–1053.CrossRefPubMedGoogle Scholar
  11. 11.
    Iso, H., Kobayashi, M., Ishihara, J., et al. (2006). Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan public health center-based (JPHC) study cohort I. Circulation, 113, 195–202.CrossRefPubMedGoogle Scholar
  12. 12.
    Yokoyama, M., Origasa, H., Matsuzaki, M., et al. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 369, 1090–1098.CrossRefPubMedGoogle Scholar
  13. 13.
    Brouwer, I. A., Zock, P. L., Camm, A. J., et al. (2006). Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the study on omega-3 fatty acids and ventricular arrhythmia (SOFA) randomized trial. Journal of the American Medical Association, 295, 2613–2619.CrossRefPubMedGoogle Scholar
  14. 14.
    Geelen, A., Brouwer, I. A., Schouten, E. G., Maan, A. C., Katan, M. B., & Zock, P. L. (2005). Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. The American Journal of Clinical Nutrition, 81, 416–420.PubMedGoogle Scholar
  15. 15.
    Christensen, J. H., Christensen, M. S., Toft, E., Dyerberg, J., & Schmidt, E. B. (2000). Alpha-linolenic acid and heart rate variability. Nutrition, Metabolism, and Cardiovascular Diseases, 10, 57–61.PubMedGoogle Scholar
  16. 16.
    Hamaad, A., Kaeng Lee, W., Lip, G. Y., & Macfadyen, R. J. (2006). Oral omega n3-PUFA therapy (omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients. Cardiovascular Drugs and Therapy, 20, 359–364.CrossRefPubMedGoogle Scholar
  17. 17.
    Frost, L., & Vestergaard, P. (2005). n-3 fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish diet, cancer, and health study. The American Journal of Clinical Nutrition, 81, 50–54.PubMedGoogle Scholar
  18. 18.
    Brouwer, I. A., Heeringa, J., Geleijnse, J. M., Zock, P. L., & Witteman, J. C. (2006). Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam study. American Heart Journal, 151, 857–862.CrossRefPubMedGoogle Scholar
  19. 19.
    Burr, M. L., Ashfield-Watt, P. A., Dunstan, F. D., et al. (2003). Lack of benefit of dietary advice to men with angina: Results of a controlled trial. European Journal of Clinical Nutrition, 57, 193–200.CrossRefPubMedGoogle Scholar
  20. 20.
    Raitt, M. H., Connor, W. E., Morris, C., et al. (2005). Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: A randomized controlled trial. Journal of the American Medical Association, 293, 2884–2291.CrossRefPubMedGoogle Scholar
  21. 21.
    Wilhelm, M., Tobias, R., Asskali, F., et al. (2008). Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure. American Heart Journal, 155, 971–977.CrossRefPubMedGoogle Scholar
  22. 22.
    NIH. (2004). Working group report on future of clinical research directions on omega-3 fatty acids and cardiovascular disease.Google Scholar
  23. 23.
    Brouwer, I. A., Geelen, A., & Katan, M. B. (2006). n-3 fatty acids, cardiac arrhythmia and fatal coronary heart disease. Progress in Lipid Research, 45, 357–367.CrossRefPubMedGoogle Scholar
  24. 24.
    “The Vitamin D and Omega-3 Trial (VITAL):” Available at: http://www.vitalstudy.org. Accessed on: 16 July 2010.
  25. 25.
    Matthan, N. R., Jordan, H., Chung, M., Lichtenstein, A. H., Lathrop, D. A., & Lau, J. (2005). A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism, 54, 1557–1565.CrossRefPubMedGoogle Scholar
  26. 26.
    Billman, G. E., Hallaq, H., & Leaf, A. (1994). Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proceedings of the National Academy of Sciences of the United States of America, 91, 4427–4430.CrossRefPubMedGoogle Scholar
  27. 27.
    Billman, G. E., Kang, J. X., & Leaf, A. (1999). Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation, 99, 2452–2457.PubMedGoogle Scholar
  28. 28.
    Billman, G. E., Kang, J. X., & Leaf, A. (1997). Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids, 32, 1161–1168.CrossRefPubMedGoogle Scholar
  29. 29.
    Billman, G. E., Nishijima, Y., Belevych, A. E., et al. (2010). Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies. American Journal of Physiology. Heart and Circulatory Physiology, 298, H1219–H1228.CrossRefPubMedGoogle Scholar
  30. 30.
    Xiao, Y. F., Sigg, D. C., & Leaf, A. (2005). The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. The Journal of Membrane Biology, 206, 141–154.CrossRefPubMedGoogle Scholar
  31. 31.
    Xiao, Y. F., Ke, Q., Chen, Y., Morgan, J. P., & Leaf, A. (2004). Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells. Biochemical and Biophysical Research Communications, 321, 116–123.CrossRefPubMedGoogle Scholar
  32. 32.
    Verkerk, A. O., van Ginneken, A. C., Berecki, G., et al. (2006). Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovascular Research, 70, 509–520.CrossRefPubMedGoogle Scholar
  33. 33.
    Xiao, Y. F., Kang, J. X., Morgan, J. P., & Leaf, A. (1995). Blocking effects of polyunsaturated fatty acids on Na + channels of neonatal rat ventricular myocytes. Proceedings of the National Academy of Sciences of the United States of America, 92, 11000–11004.CrossRefPubMedGoogle Scholar
  34. 34.
    Leaf, A., Kang, J. X., Xiao, Y. F., & Billman, G. E. (2003). Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation, 107, 2646–2652.CrossRefPubMedGoogle Scholar
  35. 35.
    Kang, J. X., & Leaf, A. (1995). Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochemical and Biophysical Research Communications, 208, 629–636.CrossRefPubMedGoogle Scholar
  36. 36.
    Kang, J. X., Xiao, Y. F., & Leaf, A. (1995). Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proceedings of the National Academy of Sciences of the United States of America, 92, 3997–4001.CrossRefPubMedGoogle Scholar
  37. 37.
    Den Ruijter, H. M., Verkerk, A. O., Berecki, G., Bakker, D., van Ginneken, A. C., & Coronel, R. (2006). Dietary fish oil reduces the occurrence of early afterdepolarizations in pig ventricular myocytes. Journal of Molecular and Cellular Cardiology, 41, 914–917.CrossRefGoogle Scholar
  38. 38.
    Den Ruijter, H. M., Berecki, G., Verkerk, A. O., et al. (2008). Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation, 117, 536–544.CrossRefGoogle Scholar
  39. 39.
    Xiao, Y. F., Ke, Q., Wang, S. Y., et al. (2001). Single point mutations affect fatty acid block of human myocardial sodium channel alpha subunit Na + channels. Proceedings of the National Academy of Sciences of the United States of America, 98, 3606–3611.CrossRefPubMedGoogle Scholar
  40. 40.
    Xiao, Y. F., Wright, S. N., Wang, G. K., Morgan, J. P., & Leaf, A. (2000). Coexpression with beta(1)-subunit modifies the kinetics and fatty acid block of hH1(alpha) Na(+) channels. American Journal of Physiology. Heart and Circulatory Physiology, 279, H35–H46.PubMedGoogle Scholar
  41. 41.
    Jahangiri, A., Leifert, W. R., Patten, G. S., & McMurchie, E. J. (2000). Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Molecular and Cellular Biochemistry, 206, 33–41.CrossRefPubMedGoogle Scholar
  42. 42.
    Lundbaek, J. A., Birn, P., Girshman, J., Hansen, A. J., & Andersen, O. S. (1996). Membrane stiffness and channel function. Biochemistry, 35, 3825–3830.CrossRefPubMedGoogle Scholar
  43. 43.
    Leaf, A., & Xiao, Y. F. (2001). The modulation of ionic currents in excitable tissues by n-3 polyunsaturated fatty acids. The Journal of Membrane Biology, 184, 263–271.CrossRefPubMedGoogle Scholar
  44. 44.
    Negretti, N., Perez, M. R., Walker, D., & O’Neill, S. C. (2000). Inhibition of sarcoplasmic reticulum function by polyunsaturated fatty acids in intact, isolated myocytes from rat ventricular muscle. Journal de Physiologie, 523(Pt 2), 367–375.CrossRefGoogle Scholar
  45. 45.
    Rodrigo, G. C., Dhanapala, S., & Macknight, A. D. (1999). Effects of eicosapentaenoic acid on the contraction of intact, and spontaneous contraction of chemically permeabilized mammalian ventricular myocytes. Journal of Molecular and Cellular Cardiology, 31, 733–743.CrossRefPubMedGoogle Scholar
  46. 46.
    Xiao, Y. F., Gomez, A. M., Morgan, J. P., Lederer, W. J., & Leaf, A. (1997). Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proceedings of the National Academy of Sciences of the United States of America, 94, 4182–4187.CrossRefPubMedGoogle Scholar
  47. 47.
    Grynberg, A. (2005). Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents. Current Pharmaceutical Design, 11, 489–509.CrossRefPubMedGoogle Scholar
  48. 48.
    Engelbrecht, A. M., Engelbrecht, P., Genade, S., et al. (2005). Long-chain polyunsaturated fatty acids protect the heart against ischemia/reperfusion-induced injury via a MAPK dependent pathway. Journal of Molecular and Cellular Cardiology, 39, 940–954.CrossRefPubMedGoogle Scholar
  49. 49.
    Nair, S. S., Leitch, J. W., Falconer, J., & Garg, M. L. (1997). Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. The Journal of Nutrition, 127, 383–393.PubMedGoogle Scholar
  50. 50.
    Arterburn, L. M., Hall, E. B., & Oken, H. (2006). Distribution, interconversion, and dose response of n-3 fatty acids in humans. The American Journal of Clinical Nutrition, 83, 1467S–1476S.PubMedGoogle Scholar
  51. 51.
    Otten, W., Iaizzo, P. A., & Eichinger, H. M. (1997). Effects of a high n-3 fatty acid diet on membrane lipid composition of heart and skeletal muscle in normal swine and in swine with the genetic mutation for malignant hyperthermia. Journal of Lipid Research, 38, 2023–2034.PubMedGoogle Scholar
  52. 52.
    Harris, W. S., Sands, S. A., Windsor, S. L., et al. (2004). Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation, 110, 1645–1649.CrossRefPubMedGoogle Scholar
  53. 53.
    Xiao, Y. F., Sigg, D. C., Ujhelyi, M. R., Wilhelm, J. J., Richardson, E. S., & Iaizzo, P. A. (2008). Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. Am J Physiol Heart Circ Physiol, 294, H2212–H2218.CrossRefPubMedGoogle Scholar
  54. 54.
    (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Gruppo italiano per lo studio della sopravvivenza nell’infarto miocardico. Lancet, 7(354):447–455.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Eric S. Richardson
    • 1
    • 2
  • Paul A. Iaizzo
    • 1
    • 3
  • Yong-Fu Xiao
    • 2
  1. 1.Departments of Biomedical Engineering and SurgeryUniversity of MinnesotaMinneapolisUSA
  2. 2.Medtronic, IncMounds ViewUSA
  3. 3.Department of SurgeryUniversity of MinnesotaMinneapolisUSA

Personalised recommendations